The DOI matches its Crossref record, with a small difference in title or year.
Cancer Diagnosis Through IsomiR Expression with Machine Learning Method
Abstract
Background: IsomiR is an isoform of microRNA (miRNA), and its sequences vary from those of a reference miRNA, which arose with the advencements of deep sequencing, high miRNA variability has been detected from the same miRNA precursor. IsomiR exists in four main types formed through the following processes: 5' or 3' trimming, Nucleotide addition, Nucleotide removal, and posttranscriptional RNA editing. Objective: For cancer diagnosis, it needs to explore differential expression profiles which can be used to distinguish cancer and normal cell lines, especially in the isomiR-mRNA regulatory networks, because aberrant isomiR expression profiles may contribute to tumorigenesis. Method: We extracted five features of the isomiR read counts from RNA-SEQ data in TCGA, with a random forest classification algorithm, these features were applied to diagnose six cancers: breast invasive carcinoma, lung adenocarcinoma, squamous-cell carcinoma of the lung, stomach adenocarcinoma, thyroid carcinoma, and uterine corpus endometrial carcinoma. Results: Compare with the classifier libD3C, our method can be utilized to distinguish cancers from their normal counterparts by performance based on sn, sp, ACC and MCC measures. Conclusion: IsomiR can be successfully and effectively used to diagnose cancer through machine learning method from high-throughput data. Keywords: MicroRNA, isomiR, cancer, machine learning, high-throughput data, RNA-SEQ data.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several researches proved that coding genes/noncoding RNAs/proteins were related to diseases, including AD [29,30,31,32,33,34,35,36].”
From An Efficient Classifier for Alzheimer’s Disease Genes Identification (2018) · cites this paper as [33]
Citations
Cited by
Sorted by citations
ACPred-Fuse: fusing multi-view information improves the prediction of anticancer peptides
Rao, B., Zhou, C., Zhang, G., Su, R., & Wei, L. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz088 · Cited by 178
Wei, L., Chen, H., & Su, R. (2018) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2018.07.004 · Cited by 179
The miRNA: a small but powerful RNA for COVID-19
Zhang, S., Amahong, K., Sun, X., Lian, X., Liu, J., Sun, H., Lou, Y., Zhu, F., & Qiu, Y. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab062 · Cited by 149
Design powerful predictor for mRNA subcellular location prediction inHomo sapiens
Zhang, Z., Yang, Y. R., Ding, H., Wang, D., Chen, W., & Lin, H. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbz177 · Cited by 136
“It has solved many bioinformatics prediction problems successfully [47–51].”
BackgroundPredicting Parkinson's Disease Genes Based on Node2vec and Autoencoder
Peng, J., Guan, J., & Shang, X. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00226 · Cited by 114
“In recent years, many methods have been proposed to predict genes associated with diseases (Peng et al., 2017a,b; Cheng et al., 2018a; Hu et al., 2018; Liao et al., 2018).”
Method
Metadata
- Authors
- Liao, Z., Li, D., Wang, X., Li, L., & Zou, Q.
- Affiliations
- Fujian Medical University (CN)
- Department of Internal Medicine-Oncology, The Fourth Hospital in Qinhuangdao, Qinhuangdao, China
- Tianjin University (CN)
- Corresponding author
- Zou, Quan
- Venue
- Current Bioinformatics
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2018-02-19
- Volume
- 13
- Issue
- 1
- Pages
- 57-63
- ISSN
- 1574-8936 (ISSN-L)
- OpenAlex
- W2427122612
- Cited by
- 130
- References
- 0
- Citations by year
- 2025: 2 · 2024: 6 · 2023: 10 · 2022: 13 · 2021: 19 · 2020: 46 · 2019: 26 · 2018: 8
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Bioinformatics (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- isomiRs, microRNA isoforms, cancer diagnosis, random forest classification, RNA-seq, invasive breast cancer, lung adenocarcinoma, lung squamous cell carcinoma, gastric adenocarcinoma, thyroid cancer, uterine corpus endometrial carcinoma, TCGA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review